People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endotronix Inc | — | Other Health Care | Series C | $116.1M | $1.6B | 2016 |
| Verax Biomedical Inc | — | Biotechnology | Series A | $45.8M | $91.8M | 2009 |
| NuCurrent, Inc. | — | Other Technology | Series A | $31.5M | $3.3M | 2014 |
| Ultrasound Medical Devices, Inc. | — | Other Health Care | Seed | $3.2M | $3.8M | 2015 |
| simMachines, Inc. | — | Other Technology | Seed | $2.2M | $75.6M | 2018 |
ROBERT ZIESERL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT ZIESERL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Goldberg | 2 | 9 |
| PAUL LAVIOLETTE | 1 | 12 |
| John Major | 1 | 9 |
| BUZZ BENSON | 1 | 8 |
| Fouad Azzam | 1 | 8 |
| Daniel Einhorn | 1 | 7 |
| Wayne Wager | 1 | 6 |
| Michael Seedman | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Keith Browning | 1 | 4 |
| MARC E. GOLDBERG | 1 | 4 |
| Robert Flanagan | 1 | 4 |
| JOE DEL GUERCIO | 1 | 4 |
| John Flavin | 1 | 4 |
| Thomas Kinnear | 1 | 3 |
| Christopher J Jensen | 1 | 3 |
| James Lousararian | 1 | 3 |
| Robert Shaw | 1 | 3 |
| HEATHER GRISHAM | 1 | 2 |
| W. CHRISTOPHER BADE | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.